Language
中文 ENGLISH
News Center
Share the latest news with you
Ovarian Cancer (SABRINA Study, 3L+,BRCAm)*Pivotal study
2025-01-22
Last
Ovarian Cancer (FLAMES Study, 1L maintenance)
Next
Cell Lung Cancer (combo with Temozolomide)*ODD
Return to list
Our Science
Press Release
Event Review
News Recommendation

Address: 27th Floor, New Bund Times Square, 399 Haiyang West Road, Pudong New Area, Shanghai, China

TEL：021-68411121

Email: info@impacttherapeutics.com

Address: Room 2506, Jingfeng Center, No. 1698 Shuanglong Avenue, Jiangning District, Nanjing

TEL: 025-52283667

Email: info@impacttherapeutics.com

Copyright (c) 2013 IMPACT Therapeutics. All Rights Reserved 沪ICP备2024107649号 互联网药品信息证书编号:(沪)-非经营性-2025-0012 /Clinical Trial Privacy Notice / Privacy Notice / Legal Statement